Xenpozyme 20 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FFCL8
Awardee
Awarding agency
Obligated
$70,394

Award facts

Contract value 100% obligated
$70,393.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $70,393.68 delivery order to DMS Pharmaceutical Group Inc. on March 25, 2026, for Xenpozyme 20 mg vials under firm fixed-price terms.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499,999,999 ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, IL. Ultimate completion date for this delivery order is April 15, 2026.

Quick answers

Who was awarded contract SPE2DR26FFCL8?

SPE2DR26FFCL8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 25, 2026.

How much is contract SPE2DR26FFCL8 worth?

The government has obligated $70,394 on SPE2DR26FFCL8.

Is contract SPE2DR26FFCL8 an order under another contract?

Yes. SPE2DR26FFCL8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.

Was contract SPE2DR26FFCL8 competed?

The extent of competition for SPE2DR26FFCL8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login